青蒿琥酯联合左氧氟沙星对耐碳青霉烯类大肠埃希菌抗菌活性的影响
Effect of artesunate combined with levofloxacin on antibacterial activity of carbapenem-resistant Escherichia coli
- 北京中医药 2024年43卷第2期 页码：161-166
- 作者机构：
1.中国中医科学院望京医院检验科，北京 100102
2.北京中医药大学东方医院检验科，北京 100078
- 作者简介：
董国伟，男，40岁，大学本科，副主任技师。研究方向：微生物检验。
杨琦，E-mail：1014413979@qq.com
- 基金信息：国家自然科学基金面上项目(81973638)
DOI：10.16025/j.1674-1307.2024.02.010
中图分类号：纸质出版日期：2024-02-25，
收稿日期：2023-07-06，
扫 描 看 全 文
董国伟，唐新宁，钟英成，等.青蒿琥酯联合左氧氟沙星对耐碳青霉烯类大肠埃希菌抗菌活性的影响［J］.北京中医药，2024，43（2）：161-166.
DONG Guo-wei,TANG Xin-ning,ZHONG Ying-cheng,et al.Effect of artesunate combined with levofloxacin on antibacterial activity of carbapenem-resistant Escherichia coli[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(02):161-166.
董国伟，唐新宁，钟英成，等.青蒿琥酯联合左氧氟沙星对耐碳青霉烯类大肠埃希菌抗菌活性的影响［J］.北京中医药，2024，43（2）：161-166. DOI： 10.16025/j.1674-1307.2024.02.010.
DONG Guo-wei,TANG Xin-ning,ZHONG Ying-cheng,et al.Effect of artesunate combined with levofloxacin on antibacterial activity of carbapenem-resistant Escherichia coli[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(02):161-166. DOI： 10.16025/j.1674-1307.2024.02.010.
摘要
目的
2
探讨青蒿琥酯与抗生素联用对耐碳青霉烯类大肠埃希菌（CRECO）抗菌活性的影响。
方法
2
收集分离的CRECO 20株，采用肉汤稀释法测定抗菌物质青蒿琥酯（ASN）、左氧氟沙星（LEV）、头孢他啶（CAZ）、亚胺培南（IMP）最小抑菌浓度（MIC）。用棋盘法测定ASN与LEV、CAZ、IMP协同抗菌活性；用细菌生长曲线法观察不同处理组CRECO临床菌株（E5）生长的情况；用RT-PCR检测外排泵基因以及调控基因的表达。
结果
2
抗菌物质ASN、LEV、CAZ、IMP的MIC50分别为>8 192、64、2 048、32 µg/mL。协同抗菌试验显示：ASN（1 024 µg/mL）与LEV联用时，LEV的MIC50由64 µg/mL降至16 µg/mL（即1/4 MIC50），联合作用效果以协同为主；与CAZ联用时，CAZ的MIC50由2 048µg/mL降至1 024 µg/mL（即1/2 MIC50），联合作用效果以相加为主。生长曲线显示，ASN联合LEV能有效抑制CRECO生长，曲线走向平缓。20株菌株全部携带外排泵基因AcrA和AcrB基因。RT-PCR结果显示ASN联合LEV可降低外排泵基因AcrB表达。
结论
2
ASN对CRECO无抗菌活性，但ASN联合LEV能有效增强抗生素的抑菌作用，其协同抑菌机制与降低外排泵基因AcrB表达相关。
Abstract
Objective
2
To investigate the effect of artesunate combined with levofloxacin on the antibacterial activity of carbapenem-resistant Escherichia coli（CRECO）.
Methods
2
20 strains of CRECO isolated from the laboratory were collected and the minimum inhibitory concentrations （MIC） of artesunate， levofloxacin， ceftazidime and imipenem were determined by broth microdilution methods. The synergistic antibacterial activity of artesunate with levofloxacin， ceftazidime and imipenem was determined by broth microdilution checkerboard methods. The effects of different treatment groups on the growth of clinical strain （E5）of CRECO were observed by bacterial growth curve method. The expression of efflux pump gene and regulatory gene was detected by RT-PCR.
Results
2
The MIC50 of artesunate， levofloxacin， ceftazidimeandimipenem were >8 192，64，2 048 and 32 µg/mL， respectively. Synergistic antibacterial test showed that when artesunate was combined with levofloxacin at 1 024 µg/ mL， the MIC50 decreased from 64 µg/mL to 16 µg/mL （i.e.，1/4 MIC50）， and the combined effect was mainly synergistic. When combined with ceftazidime， its MIC50 decreased from 2 048 µg/mL to 1 024 µg/mL （i.e.，1/2 MIC50）， and the combined effect was mainly additive. The results of the growth curve showed that artesunate combined with levofloxacin could effectively inhibit the growth of CRECO， and the curve tended to be flat. All 20 strains carried the efflux pump genes， AcrA and AcrB genes. RT-PCR results showed that artesunate combined with levofloxacin could reduce the expression of efflux pump gene AcrB. The decrease of its expression level was associated with the decreased expression of the regulatory gene AcrB.
Conclusion
2
Artesunate has no antibacterial activity against CRECO， but artesunate combined with levofloxacin could effectively enhance the antibacterial action of antibiotics， and its synergistic inhibitory mechanism may be related to the reduction of the expression of efflux pump gene AcrB.
关键词
青蒿琥酯耐碳青霉烯类大肠埃希菌左氧氟沙星抗菌活性
Keywords
Artesunatecarbapene-resistant Escherichia coliLevofloxacinantibacterial activity
references
国家卫生健康委合理用药专家委员会,全国细菌耐药监测网.2019年全国细菌耐药监测报告[J]中国合理用药探索,2021,18(3):1-11.
ZHANG Y,WANG Q,YIN Y,et al.Epidemiology of carbapenem-resistant enterobacteriaceae infections:report from the China CRE network[J].Antimicrob Agents Chemother, 2018,62(2):1882-1817.
柯唯心,李天萌,吕媛.2019年至2020年碳青霉烯类耐药大肠埃希菌的分子流行病学研究[J].中国临床药理学杂志,2022,38(22):2762-2765.
兰小琴,林楠,杨大超,等.10种中药颗粒剂对耐碳青霉烯类肠杆菌体外抑菌作用研究[J].中国医药导报,2020,17(13):169-172.
FENG FB,QIU HY.Effects of Artesunate on chondrocyte proliferation,apoptosis and autophagy through the PI3K/AKT/mTOR signaling pathway in rat models with rheumatoid arthritis[J].Biomed Pharmacother,2018,102:1209-1220．
LI XZ,PlESIAT P,NIKAIDO H.The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria[J].ClinMicrobiol Rev,2015,28(2):337-418.
邢龄艺,荆瑶瑶,冯京,等.细菌耐药机制研究进展及新药研发策略[J].天津中医药大学学报,2023,42(1):127-136.
杜静怡,王铖,郭君慧,等.细菌RND外排泵的结构与作用机制研究进展[J].中国抗生素杂志,2022,47(10):994-1001.
AZARGUN R,GHOLIZADEH P,SADEGHI V,et al.Molecular mechanism associated with quinolone resistance in enterobacteriace: review and up date[J].Trans R Soc Trop Med Hyg,2020,114(10):770-781.
蒋沅岐,董玉洁,周福军,等.青蒿素及其衍生物的研究进展[J]中草药,2022,53(2):599-608.
吕品,秦玉花,王山梅,等.青蒿琥酯对耐甲氧西林金黄色葡萄球菌体外抗菌活性研究[J].中华实用诊断与治疗杂志,2015,29(7):643-644.
晏国威,马小华,潘建华,等.青蒿琥酯联合头孢菌素类药物对多重耐药肺炎克雷伯菌抗菌活性的分析[J].基因组学与应用生物学,2021,40(3):1391-1399.
马小华,晏国威,石国民,等.青蒿琥酯联合碳青霉烯类药物对耐药结核分枝杆菌抗菌活性研究[C].中华医学会结核病学分会2019年全国结核病学术大会论文汇编,2019:8.
YASSINE I,RAFEI R,OSMAN M, et al.Plasmid-mediated quinolone resistance:Mechanisms,detection,and epidemiology in the Arab countries[J].Infect Genet Evol,2019,76:104020.
LI B,YAO Q,PAN XC,et al.Artesunate enhances the antibacterial effect of {beta}-lactam antibiotics against Escherichia coli by increasing antibiotic accumulation via inhibition of the multidrug efflux pump system AcrAB-TolC[J].J Antimicrob Chemother,2011,66(4):769-777.
魏思敏,汪培嘉,田启明,等.青蒿琥酯对大肠杆菌临床分离株抗生素敏感性的影响研究[J].中国兽药杂志,2019,53(9):1-6.
RUIZ J.Mechanisms of resistance to quinolones:target alterations,decreased accumulation and DNA gyraseprotection[J].J Antimi-crob chemother,2003,51(5):1109-1117.
0
浏览量
0
下载量
0
CSCD
- Meta-XML下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 技术支持由北京北大方正电子有限公司提供 京ICP备18046208号-2
京公网安备 11010102006710号 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies